Dickmeyer Boyce Financial Management, Inc.
Source: SEC Form 13F · as of Mar 2026Dickmeyer Boyce Financial Management, Inc. holds 11 biotech & pharma companies tracked by BioSniper, totaling $15.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$15.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 22,019 | $5.4M |
| ABBVAbbVie Inc. | 15,684 | $3.4M |
| MRKMerck & Co., Inc. | 9,238 | $1.1M |
| LLYELI LILLY & Co | 1,132 | $1.0M |
| AMGNAMGEN INC | 2,888 | $1.0M |
| NVSNovartis AG | 6,007 | $918K |
| ABTABBOTT LABORATORIES | 8,070 | $829K |
| PFEPFIZER INC | 22,924 | $644K |
| NVONovo Nordisk A/S | 10,505 | $386K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,341 | $363K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,920 | $216K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.